Skip to main content
. 2021 Nov 26;12:774539. doi: 10.3389/fphar.2021.774539

FIGURE 4.

FIGURE 4

Entinostat inhibits NLRP3 inflammasome activation in the spinal cord after SCI. NLRP3 inflammasome activation was measured in the spinal cord after SCI. (A) qPCR analysis of NLRP3 mRNA during 7 days post-SCI. (B) WB analysis of NLRP3, Caspase-1 expression in spinal cord after SCI at 7 days. Histogram analysis of the protein relative expression, vs. β-actin. (C) NLRP3/caspase-1 double staining was performed, and the nuclei were stained with DAPI. Scale bar: 50 μm. (D) ELISA analysis of the levels of TNF-α, IL-1β, and IL-18 in the spinal cord. (E) Caspase-1 activity was detected using Caspase-1 Activity Assay Kit after SCI. Data are expressed as the mean ± SEM, n = 5. *p < 0.05, vs. the sham + vehicle group; #p < 0.05, vs. the SCI + vehicle group.